Contact Us (781) 301-7474

Science Innovation Forum

Science & Innovation Forum – The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. When: Thursday, May 5, 2022 4:00 – 5:00 PM (ET)...

Hemanext AABB 2021

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs). Learn More...

Connect with Hemanext at ISBT 2020

Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with...